SHANGHAI, Nov. 6, 2019 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), a leading biopharmaceutical company in China focusing on oncology and autoimmune diseases, won the award of "Biosimilar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results